Minimally Invasive and Novel Therapeutics

September 8-10, 2024

2024 MINT Conference

About MINT

Current treatment strategies for patients with complex digestive disorders continue to evolve. This is largely the result of growing technological advances in surgery and endoscopy.

The goal of the Minimally Invasive and Novel Therapeutics (MINT) course is to inform physicians on how best to incorporate these technologies into their practice. Using a video-based format, our goal is technique transfer from world-renowned faculty to the community, hospital, endoscopy suite, and operating room.

MINT offers an ideal mix of traditional standard-of-care principles with a balanced and unbiased view of new, cutting-edge information. This hybrid course (in-person and virtual) engages learners through video-based lectures with recordings of surgical and endoluminal therapies, along with lively multidisciplinary panel discussions.

Digestive disease management requires multidisciplinary care. This course intends to break the barriers of subspecialty medicine by bringing together gastroenterologists, surgeons, psychologists, APPs, nurses, and dietitians to learn from each other. Since many surgeons and endoscopists learn best by “doing”, this course offers hands-on skills sessions in both endoluminal therapies and surgical techniques taught by national and international experts. The learner should leave this course with the confidence to manage patients with foregut disease employing the latest research and technology to improve patient outcomes.